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Abstract
Polyglutamine (polyQ) expansion in exon1 (XN1) of the huntingtin protein is linked to Huntington’s disease. When the
number of glutamines exceeds a threshold of approximately 36–40 repeats, XN1 can readily form amyloid aggregates
similar to those associated with disease. Many experiments suggest that misfolding of monomeric XN1 plays an important
role in the length-dependent aggregation. Elucidating the misfolding of a XN1 monomer can help determine the molecular
mechanism of XN1 aggregation and potentially help develop strategies to inhibit XN1 aggregation. The flanking sequences
surrounding the polyQ region can play a critical role in determining the structural rearrangement and aggregation
mechanism of XN1. Few experiments have studied XN1 in its entirety, with all flanking regions. To obtain structural insights
into the misfolding of XN1 toward amyloid aggregation, we perform molecular dynamics simulations on monomeric XN1
with full flanking regions, a variant missing the polyproline regions, which are hypothesized to prevent aggregation, and an
isolated polyQ peptide (Qn). For each of these three constructs, we study glutamine repeat lengths of 23, 36, 40 and 47. We
find that polyQ peptides have a positive correlation between their probability to form a b-rich misfolded state and their
expansion length. We also find that the flanking regions of XN1 affect its probability to form a b-rich state compared to the
isolated polyQ. Particularly, the polyproline regions form polyproline type II helices and decrease the probability of the
polyQ region to form a b-rich state. Additionally, by lengthening polyQ, the first N-terminal 17 residues are more likely to
adopt a b-sheet conformation rather than an a-helix conformation. Therefore, our molecular dynamics study provides a
structural insight of XN1 misfolding and elucidates the possible role of the flanking sequences in XN1 aggregation.
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Introduction
Similar to eight other neurodegenerative polyglutamine diseases
[1–5], Huntington’s disease (HD) is associated with a polygluta-
mine (polyQ) expansion in the huntingtin protein. In HD, the first
exon (XN1) of the huntingtin protein, which contains the polyQ
region, has been implicated as the pathogenic polypeptide [6–9]. It
is hypothesized that after it is cleaved from huntingtin, the XN1
polypeptides misfold and form lethal cellular aggregates or
inclusions in neuronal cells [1–5]. Evidence from in vivo studies
[6,7] indicates that XN1 polypeptides can form aggregates similar
to those observed in the neurons of afflicted patients. Despite
limited knowledge on the structure and function of XN1, some
information about its aggregation is known. The length of the
polyQ region in XN1 is inversely proportional to the age of onset
of symptoms [2,9]. Additionally, there is a threshold of
approximately 36–40 repeats, within which symptoms may or
may not develop [10]. However, beyond this threshold, lethal
symptoms eventually develop in the lifetime of the patient. These
symptoms develop earlier in the life of patients with longer repeat
lengths. In vitro kinetic studies of polyQ peptides have emulated this
clinical correlation between age and length [11,12]. Kinetic studies
of polyQ [13] aggregation suggested that the misfolding of a polyQ
monomer initiates the aggregation. Although other studies [14,15]
proposed more complex aggregation scenario, we hypothesize that
the misfolding of a polyQ monomer plays a critical role in the
formation of ordered amyloid aggregations. Similarly, the
aggregation of XN1 displays more complicated aggregation
behavior [16–18,19,20], it has been shown that the length-
dependent misfolding of polyQ sequence in the XN1 monomer
plays a critical role in the initial oligomerization and the later
formation of b-rich amyloid aggregates [20]. Here, we propose to
study the structure and dynamics of monomeric XN1, in hopes to
help illuminate the aggregation mechanism and help determine
the role of these aggregates.
Due to the structural complexity of XN1, previous experimental
and computational studies have focused on specific regions of XN1
(Fig. 1). First, by studying polyQ homopolymers (Qn), and similar
constructs, it has been shown that as the length increases, Qn
transitions from forming random coils in solution to b-sheets
[16,21–27]. Yet, at least one computational study finds no such
transition [28]. Other authors find the formation of a b-helix
[29–33], first proposed by Perutz [34]. Additionally, the polyQ
region has been shown to unfold neighboring regions [20,35–38],
which suggests the flanking regions should be included to better
model the behavior of XN1. Second, others [25,39–41] have
studied polyQ together with a polyproline domain, because XN1
has two polyproline (polyP) regions near the polyQ region (Fig. 1a).
Experimental studies of these models, indicate that the polyP
regions form polyproline type II (PPII) helices [3,40,41], which
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possibly protect against aggregation [1,3,5,20,39,40,42–44]. Last,
recent models that include the first 17 residues (Nt17) of XN1 that
are N terminal to the polyQ region have been studied [20,42,
45–47]. By studying isolated Nt17 polypeptides, investigators have
found that this region is either a compact random coil [20], an a-
helix [42,45] or both [20,46], which resists aggregation [20,46].
However, an Nt17+polyQ chimeric polypeptide was found to be
highly prone to aggregation, more so than an unflanked Qn
homopolymer [20]. Thus, the structural role of the Nt17 region in
XN1 aggregation is still unclear. Although the polyQ region has
been individually shown to aggregate through studies on Qn, its
effects are unknown in the context of the XN1 flanking regions.
For example, it is uncertain whether the Nt17 region assists
[3,20,45] or hinders [1,46,48] aggregation, and perhaps separate-
ly, to what extent the polyP region prevents aggregation.
Therefore, it is necessary to study XN1 misfolding and aggregation
in the context of flanking regions.
Despite the structural information about each region, there still
lacks a complete picture of XN1 due to the non-additive effect of
interactions between different structural elements. Here, we
perform all-atom discrete molecular dynamics (DMD) [49–52]
simulations to systematically study structural dynamics of XN1
and its variants. DMD has been shown to have a higher sampling
efficiency than traditional molecular dynamics and has been used
to study protein folding thermodynamics and protein aggregation
[53]. All-atom DMD features a transferable force field and has
been successfully used to fold several small proteins ab initio [52]
and to study the folding and misfolding dynamics of Cu, Zn
superoxide dismutase [54]. We construct 12 polypeptides (Fig. 1)
categorized into three sets. In the first set, we study XN1 in its
entirety (Fig. 1a) in order to capture the interactions between the
Nt17, polyQ and polyP flanking regions simultaneously. In the
second set, we study XN1 without the polyP flanking regions, titled
XN1-P11-P10, (Fig. 1b) in order to determine the effect of the polyP
regions on XN1 in the context of naturally occurring flanking
regions. In the third set, we study polyQ homopolymers in the
absence of all flanking regions (Qn) as controls. In each set, four
different numbers of glutamine repeats are included: 23 (non-
pathogenic), 36 (threshold), 40 and 47 (pathogenic). As originally
suggested by Perutz [36] and expanded upon by others
[1,3,20,35,36,38,55], the sequence context for a polyQ region
can alter its aggregation mechanism; here, we find a more
complete view of how the context plays a significant role in the
secondary structure. In the context of XN1, the residues in the
polyQ region have a lower probability of adopting b-sheet
conformations, due to inhibition by the polyP regions. Surpris-
ingly, by increasing the number of glutamine repeats in the polyQ
region, the Nt17 region can be induced to fold into a b-strand.
Thus, we suggest that the polyQ and flanking regions in XN1 are
strongly coupled in XN1 folding and misfolding.
Results
For each of the 12 models (Fig. 1), we perform replica exchange
DMD simulations to efficiently sample the folding landscape of the
polypeptides [56–60]. In each simulation, we start from a
completely stretched conformation. We discard the first 0.5% of
the trajectories, which have drastic energy and structural changes,
to disregard the initial equilibration; we only use the equilibrated
parts of the trajectories for analysis. First, we model XN1 (Fig. 1a)
in its entirety to simultaneously study the interactions among all
flanking regions, such as the Nt17, polyQ and polyP regions.
Second, we model a mutant of XN1 that is missing the polyP
regions: XN1-P11-P10 (Fig. 1b) to study the structural effects of the
polyP regions, which have been shown to protect against XN1
Figure 1. Constructs studied. Diagrams of the organization of the sequence regions in the (a) XN1 and (b) XN1-P11-P10 constructs are shown. The
number of residues in each region is indicated below the region. For all three constructs (XN1, XN1-P11-P10 and the homopolymer Qn, not shown) we
vary the number of repeats modeled: n=23, 36, 40, 47. In (a) XN1, the first N-terminal 17 residues are collectively referred to as the Nt17 region.
Following Nt17 is the polyQ region, which contains a variable n number of glutamine repeats. P11 and P10 are the regions of 11 and 10 proline repeats
respectively; they are referred to as the polyP regions. A region of 17 residues tethers the polyP regions together. Finally, there are 12 residues in the
C-terminus of XN1. The (b) XN1-P11-P10 construct is identical to XN1 with the exception that it does not contain the polyP regions. The XN1 sequence
is explicitly written in Fig. 4d. We use the title of ‘‘construct’’ to refer to either XN1, XN1-P11-P10 or Qn. A ‘‘model’’ is a specific polypeptide, such as




Huntington’s Disease is a neurodegenerative disorder
associated with protein aggregation in neurons. The
aggregates formed are thought to lead to neurotoxicity
and cell death. Understanding the molecular structure of
these aggregates may lead to strategies to inhibit
aggregation. Exon 1 (XN1) of the huntingtin protein is
critical for aggregate formation. This polypeptide has a
naturally occurring polyglutamine sequence (polyQ),
which is elongated in patients afflicted with the disease.
The polyQ region in XN1 has several flanking sequences
with distinct physicochemical properties, including the N-
terminal 17 residues, two polyproline regions, and C-
terminal sequences, that may affect its overall structure
and aggregation. What is the overall structure of XN1, and
what structural effects do the neighboring sequences have
on each other and polyQ? We address these questions by
studying computational models of various polypeptides,
including XN1 and three mutant forms associated with
Huntington’s Disease. Certain neighboring sequences are
found to inhibit aggregation, while others may be
recruited by polyQ to form aggregates. Our results suggest
the role that the flanking sequences may play in XN1
aggregation and may subsequently guide future structural
models of XN1 aggregation.
Flanking Sequences Modulate Huntingtin Misfolding
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XN1-P11-P10 models, we can determine the role of the polyP
regions. Lastly, as controls, we model Qn homopolymers in the
absence of all flanking regions.
XN1Qn are less stable than Qn and XN1Qn-P11-P10
We apply the weighted histogram analysis method (WHAM) to
analyze the folding thermodynamics of all simulated peptide
systems [61]. For each peptide model, we calculate the heat
capacity (CV) at different temperatures (Fig. 2). We find Q23
undergoes a non-cooperative folding transition from an extended
and unfolded state to a collapsed globule state, characterized by
the broad and shallow CV peak (Fig. 2a). Similar peaks, indicating
a coiled-globule transition of a polyQ system, have been
documented elsewhere [14]. As the length of Qn increases, the
heat capacity peak gets taller and narrower, suggesting an
increased folding cooperativity. In all three constructs (XN1,
XN1-P11-P10 and Qn) we find the transition temperature
corresponding to the CV peak (Fig. 2 and Table S1) is almost
unaffected by the length of the polyQ region. Since the transition
temperature is indicative of the polypeptide stability, our
simulation suggests that the length of the polyQ region does not
affect the stability of the polypeptides. Interestingly, we find that
the average transition temperature for the XN1 models (311 K) is
smaller than that of the Qn (322 K) and the XN1-P11-P10 (340 K)
models. The differences in transition temperatures indicate the
XN1-P11-P10 models are the most stable, followed by the Qn
models and lastly, the XN1 models are the least stable.
Qn transitions from random coil to b-sheet
As suggested by the Wetzel group and others [11,13,19],
misfolding of polyQ monomers might initialize the aggregation
and play a crucial role in the formation of amyloid fibrils. The
peptide of polyQ is naturally unstructured, and thus, the length-
dependent aggregation behavior can only be explained by the rare
and spontaneous misfolding of the peptide. Therefore, we focus on
the compact low-energy state from simulations (see Methods). The
compact low-energy state usually constitutes only 13–27% of the
total populations (Table S2). Among this subset of compact
structures, we find a representative structure using a clustering
algorithm (see Methods). These representative structures are not
definitive misfolded states, but rather represent common, acces-
sible compact states. We find that Qn is able to form a b-sheet for
all lengths modeled (Fig. 3d). As the length of Qn increases, the b-
sheet expands and contains more b-strands. Even the shortest
polypeptide, Q23, is capable of forming a small b-sheet (a b-
hairpin); although, this structure rarely forms during the
simulation (Fig. 3d). Additionally, we calculate the probability of
observing a given secondary structure for each residue (Fig. 3a,b,c)
in the compact state (see Methods). For example, we find that in
Q47 there are many segments of the polypeptide featuring high b-
conformation (Fig. 3c). Although the probability is computed for
each residue, a high probability of b-conformation for consecutive
residues indicates the formation of a b-strand (Fig. 3d). Further-
more, an overall perspective is gained when this probability is
averaged over multiple residues (Figs. 3a and 3b). We find the
compact states of Q23 to be primarily unstructured; a typical
residue in Q23 is a random coil 67% of the time. In contrast, the
residues in the long Qn models of Q36–47, have b-sheet dihedral
angles 40% of the time. That is, residues in the long Qn models
adopt b-sheet conformations almost 2.5 times more often than Q23
(Fig. 3a). The relatively high b-sheet probabilities do not
contradict the experimental observations of little to no monomeric
b-sheet structure [19,15,25], since the secondary structure
probability calculation is computed only for the small subset of
compact and low-energy states. Additionally, the structural
ensembles are constructed from the replica exchange simulations,
which cover a wide-range of temperatures (see Methods). As a
result, the distribution of conformations does not correspond to a
single experimental condition, and thus, cannot be compared with
experimental measurements. However, these ensembles can be
used to evaluate the structural propensities of various polyQ
constructs. From our calculations of the compact polypeptide, we
find that Qn residues tend to transition from random coil
conformations at short lengths, to b-sheet conformations at long
lengths.
PolyP hinders b-sheet formation of polyQ in XN1
In the XN1 model, the polyQ region is surrounded by multiple
flanking regions (Fig. 1), including the Nt17 and polyP regions. We
find that for n=36, 40 and 47, the residues in the polyQ region
adopt b-sheet conformations approximately 10% less frequently
than residues in isolated Qn (Fig. 3a). Thus, the flanking regions
can lower the probability of the residues in the polyQ region to
adopt b-sheet conformations. Based on secondary structure
probabilities (data not shown) and the corresponding representa-
Figure 2. Thermodynamics of the peptides. Heat capacity and temperature curves are calculated with WHAM analysis of the simulation
trajectories. (a) Calculations of the Q23,Q 36,Q 40 and Q47 models indicate the folding transition peaks become taller and narrower for longer
glutamine lengths. (b) For the XN1Q23, XN1Q36 and XN1Q47 models, the transition temperatures are nearly identical (308K, 308K and 304K
respectively). However, the XN1Q40 model has a larger transition temperature around 325K. (c) The XN1Q23-P11-P10, XN1Q36-P11-P10, XN1Q40-P11-P10
and XN1Q47-P11-P10 models have varied transition peaks. The transition temperatures are 365K, 335K, 317K and 343K respectively. Detailed data on
the peak positions are found in Table S1.
doi:10.1371/journal.pcbi.1000772.g002
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XN1 consistently form PPII helices (Fig. 4c). It is unlikely that the
polyP regions fold into PPII helices due to interactions from
neighboring regions. This is because the PPII helices are
consistently found in every one of the compact structures; whereas,
the other regions have more variable secondary structures. Thus,
the polyP regions are likely forming PPII helices independently.
We hypothesize that the P11 and P10 regions dominate the fold of
XN1, by forming these PPII helices, and subsequently, the
remaining regions, including the polyQ region, are affected by
these two PPII helices.
In order to study the effect of the PPII helices on the polyQ
region, we perform simulations of XN1-P11-P10 polypeptides that
are sequentially identical to XN1 but lack the polyP regions
(Fig. 1b). We find that residues in the polyQ region of XN1-P11-
P10 models adopt b-sheet conformations 10% more often than
Figure 3. Secondary structure probabilities. Selected secondary structure probabilities of residues in the (a) polyQ region, the (b) Nt17 region
and (c) each residue of Q47. Lastly, (d) representative structures of Qn.( a) In the XN1 and XN1-P11-P10 models, polyQ residues have an almost constant
b-strand probability for varying number of glutamine repeats. For all lengths of polyQ in XN1, the polyQ residues have a 31%64% b-strand
probability. For all lengths of polyQ in XN1-P11-P10, the polyQ residues have a 42%61% b-strand probability. In the context of Qn, however, the
glutamine residues for long Qn lengths have an increase in b-strand probability and a decrease in the random coil probability (data not shown). On
average, for n=36, 40 and 47, residues in the Qn polypeptides are 9% more likely to adopt b-strand conformations than the polyQ residues in the XN1
polypeptides. For the same polyQ lengths, polyQ residues in XN1-P11-P10 and all the residues in Qn have an average difference of less than 1% in b-
strand probability. (b) We show the a-helix and b-strand probabilities of the Nt17 residues as the length of the neighboring polyQ region increases.
For XN1Q23, we find the probabilities of forming an a-helix or b-strand are similar; the difference is less than 1%. However, when the polyQ length
increases (XN1Q36–47), the difference becomes more than 20% in favor of a b-strand. Contrarily, we find that the Nt17 residues in XN1-P11-P10 models
consistently prefer b-strand dihedral angles over a-helix dihedral angles; the difference is over 20% for each length of polyQ. (c) As an example, we
present the probability of each residue in Q47 to have a b-sheet conformation. There are continuous stretches of high probabilities: residues 2–8, 11–
17, 21–29 and 34–45. These stretches are likely the locations of continuous b-strands. The residues with surprisingly low b-sheet conformation are the
location of turns between b-strands. The periodic shape of the graph indicates a b-sheet similar to the one in panel d). The average of all these
probabilities is 42%; it is one data point in panel a). (d) These are representative structures of the Qn polypeptides determined through clustering. Q23
shows a b-hairpin, and although this structure is from the largest cluster, it represents only 6% of all the structures used for clustering (see methods).
Therefore, it is rare, but possible, for Q23 to adopt a b-hairpin conformation. The longer homopolymers are more likely to adopt a conformation
similar to the ones depicted here; Q36,Q 40 and Q47 represent 50%, 23% and 40% of their respective clustered structures (Table S3). Most strands are
between 6 and 9 residues long. Intra-backbone hydrogen bonds are shown only for those residues forming b-strands. Secondary structures are
automatically calculated by PyMOL and are not used to calculate probabilities.
doi:10.1371/journal.pcbi.1000772.g003
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n=36, 40 and 47, the polyQ residues in the XN1-P11-P10 and Qn
models have nearly equal b-sheet probabilities (Fig. 3a). Thus, the
decrease in the probability of the polyQ region to form b-sheets in
XN1 may be attributed to the polyP regions that form PPII
helices. This relationship is consistent with experimental observa-
tions which show the polyP regions inhibit polyQ aggregation and
toxicity [1,3,5,20,39,40,42–44].
Nt17 can be induced into a b-strand
It has been experimentally shown that the Nt17 region can be a
tight random coil [20,46] or an a-helix [20,45,46,48]. However,
once fused to the polyQ region, the Nt17 region promotes the
aggregation of polyQ [20,47]. To investigate the impact of the
Nt17 region in XN1 misfolding, we study the Nt17 region in the
context of XN1. From secondary structure probabilities of the
XN1 and XN1-P11-P10 models, we find the Nt17 residues adopt
random coil conformations over 50% of the time, regardless of the
polyQ length. This observation is consistent with the previous [20]
study in that the Nt17 region is most likely to be a random coil in
the context of XN1. We also characterize the a-helix and b-sheet
conformation probabilities for the Nt17 residues. For the XN1
models, we find that the likelihood of Nt17 residues forming an a-
helix or b-strand conformation is correlated with the length of the
neighboring polyQ region (Fig. 3b). In the shortest model,
XN1Q23, the residues in the Nt17 region are equally likely to
adopt an a-helix or b-sheet conformation. However for longer
models, XN1Q36–47, the Nt17 residues adopt a b-sheet confor-
mation at least six times more often than an a-helix conformation.
In fact, for the longest model, XN1Q47, the Nt17 residues sample
b-sheet dihedral angles 30 times more frequently than a-helix
dihedral angles (Fig. 3b). The representative structures of the
XN1Q23 and XN1Q47 models depict an example of this transition
from an a-helix to a b-strand (Figs. 4a and 4b). Thus, in the
context of XN1, we find that as the polyQ length increases, the
Nt17 residues significantly prefer a b-sheet conformation over an
a-helix conformation. That is, by elongating the polyQ region, the
Nt17 region can be induced into a b-strand.
In the absence of the polyP regions, the Nt17 residues have
different secondary structure probabilities. First, for all lengths of
polyQ, the Nt17 residues in the XN1-P11-P10 models show a
preference for adopting b-sheet rather than a-helix conformations.
Even for the shortest polyQ length, the Nt17 residues prefer b-
sheet dihedral angles (Fig. 3b). Thus, at least in the case of 23
glutamine repeats, the Nt17 region must be either directly or
indirectly affected by the polyP regions; such that, by removing the
polyP regions, the Nt17 region is more likely to form a b-strand.
Second, for n=36, 40 and 47, the Nt17 residues are nearly equally
likely to adopt b-sheet conformations in either the XN1 or XN1-
P11-P10 constructs (Fig. 3b). Therefore, for long polyQ lengths, the
polyP regions in XN1 have little effect on the b-sheet probability of
the Nt17 region.
Figure 4. Representative structures of XN1. Structures that are representative of (a) XN1Q23 and (b) XN1Q47 are shown. A detailed view of the
polyP regions from the XN1Q23 structure is also presented (c). Pink residues are glutamines; blue residues are prolines, and all other residues are
colored green. The sequence for XN1 is shown (d) for n=23 as in panel a). The coloring in the sequence matches the coloring of the polypeptide
backbones in both structures. The (a) XN1Q23 and (b) XN1Q47 structures respectively represent 37% of 1036 clustered structures and 17% of 1032
clustered structures (see methods and Table S3). From these example conformations, we see some structural correlations that complement the
secondary structure probability calculations (Fig. 3). First, no drastic change in the b-strand structure of the polyQ region is seen between the XN1Q23
and XN1Q47 structures. Second, the a-helix in the Nt17 region of (a) XN1Q23 has transformed into a b-strand in (b) XN1Q47. Third, the two polyP
regions form (c) PPII helices. The probability data (not shown) indicates that these PPII helices exist in 100% of the partially folded structures. The
intra-main chain hydrogen bonds are shown for those residues forming b-strands. As in Fig. 3d, the secondary structures are assigned by PyMOL. (d)
The sequence is divided into the same regions as outlined in Fig. 1a.
doi:10.1371/journal.pcbi.1000772.g004
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The length dependence of Qn aggregation
One intriguing phenomena of glutamine expansion diseases is
the length dependence of disease onset [2,9]. It has been suggested
that both short and long Qn polypeptides can access similar
misfolded structures that lead to aggregation, but the frequency at
which this misfolded structure is visited depends on the length of
Qn [62]. That is, long Qn aggregate fast, because they misfold
frequently; contrarily, short Qn rarely misfold and thus aggregate
slow. Mounting experimental evidences support this model by
showing that, regardless of length, Qn polypeptides form
aggregates of similar structure [25,27,28,39,62], which suggests
the misfolded structures for all Qn are also similar. Additionally,
kinetic studies [16,21–27] verify the correlation between the length
of the Qn polypeptide and the rate at which it aggregates in
solution. The remaining question is to determine the common
misfolded structure that leads to aggregation. To this end, some
investigators [8,11,16–18] have suggested that early forms of Qn
aggregates have high amounts of b-sheets. In the previous
investigation by Wetzel’s group, [11] glutamine homopolymers
were capped by flanking lysine residues (K2QnK2) to increase the
peptide solubility [63]. It has been argued that the electrostatic
repulsion between flanking lysines might prevent the formation of
compact structures and alter the aggregation kinetics of the
peptide system [19]. As the length increases, the screening effect
reduces. Hence, despite the screening effect, the observation of
intrinsic b-sheets formation of polyQ peptides is still valid. Our
resulting extended b-sheet structures are prone to aggregation with
exposed hydrogen bond donors and acceptors found in the
polypeptide backbone [64]. By seeking to satisfy these bonds, the
polypeptides can form bonds with other polypeptides that similarly
have an exposed backbone, leading to the formation of large
aggregates.
Our simulations of Qn support a model, similar to one outlined
by [27], wherein a common, compact misfolded state is accessible
to most Qn monomers and rates of misfolding are length-
dependent. Accordingly, we find that partially folded monomers
of both short and long Qn polypeptides can have high amounts of
b-character (Fig. 3d). Additionally, we find that the residues in
long Qn models, with 36 or more repeats, are more likely to have
b-sheet conformations than short models, Q23 (Fig. 3a). The
secondary structure probability of each individual residue is
proportional to the probability of the overall polypeptide adopting
that secondary structure. Thus we find a positive correlation
between the length of the Qn polypeptide and its probability of
forming a b-sheet. Because previous studies [8,11,16–18] have
linked b-sheet formation to aggregation, we suggest that long Qn
polypeptides are therefore more likely to form aggregates.
The polyP regions protect XN1 from aggregation
Recent studies [1,3,5,20,39,40,42–44] indicate that the addition
of a polyP region can inhibit aggregation of the polyQ region; this
inhibition has been associated [40] with a PPII helix structure in
the polyP region. We are able to find a structural effect on the
polyQ region from the formation of PPII helices in the polyP
regions. We find that the polyP regions form PPII helices and
suppress the probability of polyQ residues in XN1 to adopt b-sheet
dihedral angles. This suppression is still present for long polyQ
lengths that are associated with disease. Upon removing these PPII
helices, we find the polyQ residues are more likely to adopt b-sheet
conformations; the likelihood is similar to that of the isolated
glutamine homopolymers: Qn (Fig. 3a). This similarity indicates
that the other flanking regions of XN1 have little effect on the
probability of the polyQ region to form a b-strand. Furthermore,
by considering that b-sheet formation has been linked to
aggregation, we find that our results reflect experimental results.
That is, because the polyP regions decrease the probability of
polyQ residues adopting b-strand conformations, these polypep-
tides have a slower rate of aggregation, which is seen in other
experiments [1,3,5,20,39,40,42–44]. Additionally, the polyP
regions greatly destabilize XN1 polypeptides (Fig. 2b and 2c).
Since unfolded polypeptides in the random coil state are unlikely
to organize as an aggregate, the presence of the polyP in the XN1
sequence prevent it from folding into the aggregation-prone state.
Therefore, we hypothesize that polyP regions protect XN1 from
aggregation in two ways: 1) destabilize the polypeptide, and 2) the
PPII helices formed by polyP inhibit formation of b-sheets.
Nt17 misfolding in monomeric XN1
Currently, the role of the flanking regions in XN1 and other
polyglutamine diseases is under debate [1,3,20,45–48]. One model
[3,47] suggests that aggregation is initiated by the flanking Nt17
region. That is, initially, these flanking regions misfold and form
oligomers; subsequently, there is an increase in the local
concentration of the polyQ region, which causes the polyQ
regions to misfold into protofibrils and ultimately mature, fatal
fibrils. Others, however, contend that the native structure of the
flanking regions is one that resists aggregation [1,46,48]. In a
recent study [20], the expansion of polyQ repeats in XN1 is found
to promote the misfolding of Nt17, which leads to rapid formation
of oligomers. In particular, the structure of the Nt17 flanking
region in XN1 is one part of this debate, which we discuss here.
We find a sharp decrease in the probability of the Nt17 residues
to adopt a-helix conformations as the length of the polyQ region
increased. Concurrently, however, these residues are more likely to
have b-strand conformations for longer polyQ repeat lengths
(Fig. 3b). Hence, our results indicate misfolding of the Nt17 region;
that is, the a-helical native structure misfolds into a b-strand in the
pathogenic associated XN1 models. Our simulation of the
XN1Q47 suggests that both the Nt17 and polyQ regions
simultaneously form b-strands (Fig. 4b). A possible future direction
would be to identify the temperature at which the Nt17 residues
transition from a-helical to b-sheet conformation; a similar
calculation has been done elsewhere [65]. In terms of the problem
of the aggregation mechanism of XN1, the next step is to
determine the role these two regions play in oligomerization of
XN1. Here, our computational study suggests that the polyQ




Unlike traditional molecular dynamic simulations, we discretize
the spherically symmetric, pair-wise interaction potential in a
DMD simulation [49–52], where, the continuous potential
between any two atoms is reduced to a series of square well
potentials. Such a simplification considerably accelerates the
computation time because in square well potentials, the particles
do not experience any force except at the boundaries of the square
wells. Thus, the particles travel with constant momenta until a
boundary is reached; at such a boundary, the two particles
experience a force and are considered colliding. At a collision, the
momenta, angular momenta and energies of only the two colliding
particles are updated according to conservation laws. Thus, the
most computationally intense process is to sort the event list to
determine the next collision. Further details on the particular
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atoms, are provided in reference [52]. Each polypeptide begins in
an extended conformation; to allow for equilibration, the first 500
time units wherein the polypeptide has drastic energy and
structural changes are discarded. We simulate each polypeptide
in a cube with periodic boundaries. The dimension of the box is
chosen to be large enough to fit the extended polypeptide.
All-atom models of Qn, XN1 and XN1-P11-P10
We model each polypeptide using an united all-atom approach,
which is explained in detail elsewhere [52]. Briefly, this approach
models all heavy atoms and polar hydrogen atoms in a
polypeptide; interactions between atoms are governed by the
Medusa Force Field [66]. The interactions include van der Waals
(VDW) based on CHARMM19, orientation-dependent hydrogen
bonding and implicit solvation EEF1 [67]. Because electrostatic
interactions at long distances are weakened due to solvent
screening, we currently do not model these effects in the all-atom
DMD. Salt bridges between side chains are captured partially
through the hydrogen bonding potential [52]. Despite the
approximation of electrostatic interactions, we were able to fold
six small proteins to their native state ab initio [52]. The sequence
used to model XN1 is taken as the first 90 residues in Human
Huntingtin Protein from NCBI [68] (Fig. 4d). There are charged,
polar and non-polar groups scattered throughout the sequence.
Additionally, the particular sequence, taken from NCBI, contains
23 glutamine repeats, which is a non-pathogenic length. The
sequence is not modified except to add glutamines in the polyQ
region as indicated or to remove the P11 and P10 stretches in the
XN1-P11-P10 models.
Replica exchange DMD simulations
To efficiently sample protein conformations, we use the replica
exchange simulation technique [56–60]. With this technique, we
are able to utilize multiple, parallel simulations of identical systems
called replicas. For each of the 12 polypeptides, we perform
simulations on eight replicas with the following set of tempera-
tures: {0.85, 0.75, 0.68, 0.64, 0.6, 0.57, 0.53, 0.5}. The
temperature units are in kcal/mol/kB, or about 500K. At a
regular time interval of 500 time units (approximately 25 ps), we
consider exchanging the temperature of two replicas. We only
allow an exchange for two replicas with neighboring temperatures,
for example 0.6 and 0.64. We use a Monte-Carlo based approach
to accept or reject an exchange. The simulation length of each
replica is 1610
6 time units (,50 ns).
Structure screening
Replica exchange simulations allow us to efficiently sample the
conformational space of XN1 and its variants by simulating a wide
range of temperatures. However, we focus only on the compact
structures of the polypeptides. To screen for these compact states,
we eliminate highly extended structures, which are those with a
large radius of gyration (Rg), and we include only those with low
energy. The former criterion eliminates the transient structures
explored during the early stages of folding when the polypeptide is
far from its favored structure. The latter criterion selects for
structures further along the folding pathway, because polypeptides
lose energy during folding. We determine both the Rg cutoff (Fig.
S1) and energy cutoff (Fig. S2) from a histogram of conformations
sampled during the simulation. Each simulation produces 800,000
structures (1 conformation per 10 time units per replica). From this
entire set, a subset of roughly 100,000–200,000 structures is
selected through this screening process (Table S2). The energy
cutoff is chosen to select for the lowest energy Gaussians.
Secondary structure probabilities
The probabilities calculated here are averages over the compact
ensemble, which is a small subset of the entire population (Table
S2). Thus, the calculations do not describe the polypeptides in
general. Instead, the secondary structure likelihoods describe the
polypeptides in a partially folded state, which estimates the
misfolded structure. For each of the compact structures, we can
calculate the backbone dihedral angles (Q & y) and the
corresponding secondary structure for each residue. Then from
the ensemble of compact structures for each polypeptide model,
we compute the probability of a given residue to adopt a-helix, b-
sheet, turn or random coil dihedral angles (Fig. 3c). Furthermore,
we also determine the secondary structure probability of a set of
residues, or a region, by averaging the secondary structure
probability over those residues (Figs. 3a, 3b). For example, a b-
strand probability of 0.3 in the polyQ region means that on
average, a given residue in the polyQ region has a 30% chance of
adopting b-strand dihedral angles. These probabilities are
calculated for individual amino acids regardless of neighboring
residues. However, consecutive residues with high amount of
calculated secondary structure probability will suggest the
probability of forming specific secondary structures. Thus, this
analysis method allows for comparison of secondary structure
tendencies for polypeptides based on the compact ensemble. To
calculate the error, we compute the standard error for each value;
where the number of events is the number of times the energy of
the trajectory crossed the energy cutoff (Fig. S3). In effect, this
method counts the number of times during the folding trajectory
that the polypeptide enters or exits the compact domain of its
folding landscape.
Clustering
For visualization purposes, we identify representative structures
for each polypeptide using an hierarchical clustering algorithm
[69]. The structures used for clustering are taken from the
simulation trajectories and are separated by at least 50ps. For most
of the models studied, roughly 1500–2000 structures are used for
clustering. As exceptions, the XN1Q23 and Q23 models include
only about 1030 structures. The number of clusters is different for
each polypeptide model and varied from 101–843. Similarly, the
population of the largest cluster also varied. A detailed summary of
these values for each polypeptide model is presented in the
supplemental materials (Table S3). In this clustering scheme, the
nodes are structures and the distance between a pair of nodes is the
root mean square distance (RMSD) between the two structures.
We use the single-linkage or minimum distance criterion for
clustering. That is, the distance between a node and a cluster is
equal to the distance between that node and the closest node in the
cluster. The cutoff distance determines the size of clusters. If the
distance between a node and a cluster is less than the cutoff, we
include the node in that cluster; otherwise, we exclude the node
from that cluster. We use a RMSD cutoff of 2.5A ˚ for clustering the
XN1Q47-P11-P10 polypeptide and a 2A ˚ RMSD cutoff for all other
polypeptides. These cutoffs are chosen to maintain high structural
similarity among the nodes in a cluster (Fig. S4). We study the
centroid of each cluster, which is the most representative node or
the centermost node of a cluster. Furthermore, we select the
centroids from the largest clusters to be overall representatives of
their respective polypeptides. To gauge the significance or
reliability of the centroid, we calculate the ratio of the number
of structures present in its cluster and the total number of
structures considered for clustering. Example calculations are
reported in the captions of Figs. 3d and 4. Finally, necessary raw
data is presented in Table S3.
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Table S1 Thermodynamic Peak Values. Data corresponding to
the peaks (Fig. 2) of the heat capacity versus temperature curves
for each polypeptide modeled. Column 2 contains the values from
the position of the peaks, which is the temperature at which the
transition from folded to unfolded occurs. Column 3 contains the
corresponding heat capacities at the folding transitions. Increasing
glutamine repeat length does not correlate significantly with the
transition temperature. The XN1 and Qn models show higher
heat capacities for longer glutamine repeats.
Found at: doi:10.1371/journal.pcbi.1000772.s001 (0.03 MB
DOC)
Table S2 Compact Structure Populations. Some statistics on the
populations of compact structures that are used for analysis. Each
simulation produces 800,000 structures in total. A subset of
compact, low-energy structures is selected for analysis. Here, the
total number of these compact structures is given for each
simulation. For comparison, the percentages out of the total
800,000 structures represented by the compact populations are
also shown. Because the compact populations are only 30% or less
of the total, the polypeptides are primarily extended and
unstructured.
Found at: doi:10.1371/journal.pcbi.1000772.s002 (0.03 MB
DOC)
Table S3 Clustering Data. Statistics describing the clustering
results. For each polypeptide studied, the following values are
shown: total number of structures used for clustering (column 2),
number of clusters (column 3) and the population of the largest
cluster (column 4). A Root Mean Square Deviation (RMSD) cutoff
of 2A ˚ is used for all polypeptides, except XN1Q47-P11-P10 where
2.5A ˚ is used. Due to computational constraints, only about 1% of
all compact structures (Table S2) are used for clustering. The
structures presented in Figures 3d and 4 are centroids of the largest
cluster.
Found at: doi:10.1371/journal.pcbi.1000772.s003 (0.03 MB
DOC)
Figure S1 Example Rg Histogram. Distribution of the Radius of
Gyration (Rg). This histogram is an example from one polypeptide
(XN1Q23). The bin size is 1A ˚. Exactly 800,000 Rg values, one per
10 time units per replica, from the trajectories of all eight replicas
are used to generate the distribution. The dashed line indicates the
Rg cutoff value (20A ˚ in this case), which is used to determine
compact structures. Structures with a larger Rg than the cutoff, are
considered extended or insufficiently compact and are not
included in the compact ensemble used for further analysis. Note
the sharp peak around 16A ˚; most polypeptides produced a similar
sharp peak. This peak indicates that most conformations explored
during the simulation are compact.
Found at: doi:10.1371/journal.pcbi.1000772.s004 (0.07 MB
DOC)
Figure S2 Example Energy Histogram. Example histogram of
two replicas from one polypeptide (XN1Q23). The bin size is
1 cal/mol. The distribution for each replica is based on 1,000,000
data points: one value per time unit. Here, the data from two
replicas are pooled; therefore this distribution is based on
2,000,000 data points. The dashed line indicates the energy cutoff
value (2285 cal/mol); this cutoff applies to all replicas of this
polypeptide. The cutoff is chosen such that only the lowest energy
states are included as compact structures.
Found at: doi:10.1371/journal.pcbi.1000772.s005 (0.08 MB
DOC)
Figure S3 Trajectories Sampling the Compact Domain. Two
example trajectories that depict how the simulations explored
states that are compact and partially folded. Both trajectories are
from the XN1Q23 simulation, and each trajectory corresponds to
the particular replica indicated in the legend. The energy cutoff
value is indicated as the red line. This value is determined by a
histogram (Fig. S2). All explored states that occur below the cutoff
are considered compact and are included in the compact
ensemble.
Found at: doi:10.1371/journal.pcbi.1000772.s006 (0.13 MB
DOC)
Figure S4 Hierarchical Clustering. One example (from
XN1Q23) of how the cutoff distance for clustering is determined.
With hierarchical clustering, we are able to determine the number
of clusters remaining for a given Root Mean Square Deviation
(RMSD) cutoff. The cutoff value, indicated by the dashed line
(2A ˚), is chosen to maximize the clustering of similar structures
while avoiding clustering of unlike structures. Clustering of similar
structures occurs in the steeply descending portion of the curve
(between 1A ˚ and 2A ˚). In this region clusters are close to each other
or similar, because a very small increase in the cutoff distance joins
two clusters. Clustering of structures that are less similar occurs in
the tail end of the curve (roughly 3A ˚ or longer). Here, the clusters
are distant or dissimilar and a large increase in the cutoff distance
is required to join two clusters. Thus, a suitable cutoff is often
found after the most similar clusters have been joined (here,
between 1A ˚–1.5A ˚) and before the distant clusters are joined (2.5A ˚
and longer).
Found at: doi:10.1371/journal.pcbi.1000772.s007 (0.08 MB
DOC)
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